Skip to main content

Table 1 Patient characteristics (n = 253)

From: Correction to: Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer

Characteristics

n (%)

Follow-up duration, months, median (range)

35.3 (4.1–52.9)

Age, years, median (range)

70 (47–86)

T stage

 

 1c

49 (19.4%)

 2a

79 (31.2%)

 2b

35 (13.8%)

 2c

53 (20.9%)

 3a

27 (10.7%)

 3b

10 (4.0%)

Pretreatment PSA, ng/ml, median (range)

8.6 (3.33–187)

 < 10

147 (58.1%)

 10 ≤ 20

73 (28.9%)

 20 ≤

33 (13.0%)

Gleason score

 

 6

14 (5.5%)

 7

117 (46.2%)

 8

79 (31.2%)

 9

43 (17.0%)

 10

0 (0.0%)

D’Amico classification

 

 low

8 (3.2%)

 intermediate

88 (34.8%)

 high

157 (62.1%)

ADT

 

 none

9 (3.6%)

 neoadjuvant

87 (34.4%)

 neoadjuvant and adjuvant

157 (62.1%)

Complications, histories

 

 Diabetes mellitus

25 (9.9%)

 Internal use of anticoagulants

41 (16.2%)

 Benign prostate hyperplasia

18 (7.1%)

 TURP

4 (1.6%)

  1. PSA prostate specific antigen, ADT androgen deprivation therapy, TURP transurethral resection of the prostate